Low-dose tolvaptan for the treatment of dilutional hyponatremia in cirrhosis: a case report and literature review
{{output}}
Dilutional hyponatremia is common in decompensated cirrhosis and can be successfully treated by tolvaptan, a vasopressin V2-receptor antagonist. Data were lacking regarding the effects of tolvaptan on cirrhotic patients with a Child-Pugh score of >10 and a ser... ...
